About
NeuroQore develops neuromodulation treatments for treatment-resistant major depressive disorder and suicidality, aiming to provide faster onset therapies with fewer side effects than existing options like ECT and rTMS.
Explore NeuroQore, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.